ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,456, issued on Dec. 23, was assigned to Fondazione Istituto Italiano Di Tecnologia (Genoa, Italy) and The Regents of the University of California (Oakland, Calif.).
"Substituted pyrimidines and 1,3,5-triazines as RHOJ inhibitors" was invented by Marco De Vivo (Genoa, Italy), Anand Ganesan (Irvine, Calif.), Jose Antonio Ortega Martinez (Genoa, Italy) and Sohail Jahid (Irvine, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts or solvates thereof:It further discloses a pharmaceutical composition comprising the compounds of formula (I) and their uses, in p...